EDQM: 134th session of the European Pharmacopoeia Commission

In its session, the European Pharmacopoeia Commission adopted 91 monographs and 9 general chapters, amongst them a new general chapter on recommendations on dissolution testing (5.17.1) and two new monographs on Pramipexole dihydrochloride (2416) and Tiotropium bromide (2420) monohydrate, active substances still under patent and elaborated under the P4 Procedure, hence in close collaboration with the respective industrial partners.